John has over 30 years of experience in drug discovery and development. He started his career in the cardiovascular biology research group at Pfizer before moving to drug development as a project manager. He has supported and led candidates across many therapeutic areas and at all stages of development. He spent 10 years as a Portfolio Director – initially for projects in early development and then for the pain, GI, GU and respiratory therapeutic areas. In that time he was instrumental in the development of therapeutic area strategies that spanned the research, development and commercial areas.
He also led and contributed to a number of global initiatives that designed and implemented project management, knowledge management, risk and resource and finance management processes and systems for Pfizer globally and managed a global organisation focused on project management excellence, operations and development.
John left Pfizer in 2009 and began a new career in Project, Programme & Portfolio Management consultancy and has worked with a number of global, mid-sized, small pharma and not for profit companies on a broad range of assignments in the portfolio, programme, project and finance management areas including developing strategy and operational planning frameworks, working with individual drug project teams to craft development strategies and operational plans, improving portfolio review, governance and planning processes. More recently, he has worked with clinical groups to improve their planning capabilities and use of MS Project Online. He has a particular interest in Risk and Uncertainty Management and works to implement risk solutions with pharma clients.
John was a founder and Executive Associate of Volt Pharma Associates – a network of independent consultants across Europe that can be formed into skill based teams to provide a wide range of consultancy services. He has also been instrumental in the foundation of Phetairos.
John leads the Project and Portfolio Management practice.